Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Trends & Forecasts

Business & Regulation Trends & Forecasts

Redefining Pharma

| James Strachan

Should pharma companies transition from developing, manufacturing and pricing “drugs” to promoting “health”?

Business & Regulation Trends & Forecasts

Inside the World’s Most Expensive Pharmaceutical Market

| Maryam Mahdi

As US prices for Rx drugs continues to rise, patients are finding themselves priced out of access to much-needed medicines.

Business & Regulation Digital Technologies

How the Industrial Internet of Things is Transforming Bioprocessing

| Sponsored by GE Healthcare

Digitalization means a more productive and adaptive plant through the application of analytics to leverage connectivity and data.

Business & Regulation Trends & Forecasts

We Must Focus on Science, Not Geography

| Steve Arlington

In times of political and social upheaval, maintaining our links across borders and working closely together is more important than ever.

Business & Regulation Trends & Forecasts

Are You Suffering from Brexit Fatigue?

| James Strachan

The uncertainty surrounding the UK’s future with Europe is having a measurable effect on pharma. But it looks like the end is nowhere in sight.

Business & Regulation Trends & Forecasts

2023: Prices and Predictions

| Maryam Mahdi

How will the industry shape up over the next five years?

Business & Regulation Trends & Forecasts

Aid Africa

| Stephanie Sutton

Healthcare, fake medicines, and the need for new antibiotics – a round-up from the UK East Africa Health Summit.

Manufacture Trends & Forecasts

Under Construction: Pharma's Cannabinoid Bid

| James Strachan

The cannabis business is booming as century-old legal conventions restricting use begin to unravel. Can pharma ride the wave?

Business & Regulation Trends & Forecasts

Ask, and Ye Shall Receive

| James Strachan

Regardless of how Britain leaves the European Union, the global pharma industry must always lobby for positive change.

Business & Regulation Trends & Forecasts

Mergers and Big Decisions

| George Chressanthis, Randy Risser

Why the CVS-Aetna merger could be a transformative event for the pharmaceutical industry.

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Latest White Papers

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register